摘要
背景:Meis1是三氨基酸环延伸(TALE)同源域转录因子的成员。过去十年的研究表明,Meis1在心脏再生,干细胞功能和肿瘤发生中具有重要作用。 目的:我们最近证明敲除成人心肌细胞中的Meis1导致心肌细胞增殖的诱导。这表明靶向Meis1可能被用于心肌损伤后心肌细胞周期的操纵。此外,Meis1的造血干细胞(HSC)特异性缺失导致HSC池的体内扩增。因此,靶向Meis1不仅可导致细胞周期进入,而且还可导致HSC的离体和体内扩增。另一方面,Meis1转录调节低氧肿瘤标志物,即Hif-1α和Hif-2α的表达。 Hif-1α和Hif-2α分别参与细胞质糖酵解和活性氧(ROS)的清除。 结论:研究强调了Meis1在治疗心肌损伤,骨衰竭和癌症方面发展新的治疗方法的新角色。
关键词: Meis1,心脏再生,干细胞扩增,癌症代谢,癌症干细胞。
图形摘要
Current Drug Targets
Title:Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer
Volume: 19 Issue: 2
关键词: Meis1,心脏再生,干细胞扩增,癌症代谢,癌症干细胞。
摘要: Background: Meis1 is a member of three-amino-acid loop extension (TALE) homeodomain transcription factors. Studies in the last decade have shown that Meis1 has crucial roles in cardiac regeneration, stem cell function, and tumorigenesis.
Objective: We have recently demonstrated that knocking out of Meis1 in adult cardiomyocytes resulted in the induction of cardiomyocyte proliferation. This suggests that targeting of Meis1 might be utilized in the manipulation of cardiomyocyte cell cycle post cardiac injuries. In addition, hematopoietic stem cell (HSC) specific deletion of Meis1 leads to in vivo expansion of HSCs pool. Thus, targeting Meis1 may lead to not only cell cycle entry but also ex vivo and in vivo expansion of HSCs. On the other hand, Meis1 transcriptionally regulates the expression of hypoxic tumor markers, namely Hif-1α and Hif-2α. Hif-1α and Hif-2α are involved in the induction of cytoplasmic glycolysis and scavenging of reactive oxygen species (ROS), respectively.
Conclusion: Studies highlight emerging roles of Meis1 towards development of new therapeutic approaches in the treatment of myocardial injuries, bone failure, and cancer.
Export Options
About this article
Cite this article as:
Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer, Current Drug Targets 2018; 19 (2) . https://dx.doi.org/10.2174/1389450118666170724165514
DOI https://dx.doi.org/10.2174/1389450118666170724165514 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypocholesterolemia
Current Vascular Pharmacology Respiratory Syncytial Virus (RSV) Prevention and Treatment: Past, Present, and Future
Cardiovascular & Hematological Agents in Medicinal Chemistry Medicinal Plants and Bioactive Compounds for Diabetes Management: Important Advances in Drug Discovery
Current Pharmaceutical Design Amniotic Fluid Embolism: Moving Diagnosis Through the Time. From the Mechanical Pulmonary Vascular Occlusion Until An Immuno - Inflammatory Pathogenesis?
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Cardiovascular Drug Discovery Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design Role of PI3 Kinase Gamma in Excitation-Contraction Coupling and Heart Disease
Cardiovascular & Hematological Disorders-Drug Targets Pathophysiological and Clinical Aspects of Iron Chelation Therapy in MDS
Current Pharmaceutical Design Role of Cardiolipin in Mitochondrial Diseases and Apoptosis
Current Medicinal Chemistry Augmentation of Creatine in the Heart
Mini-Reviews in Medicinal Chemistry Transthyretin Deposition in Familial Amyloidotic Polyneuropathy
Current Medicinal Chemistry Statins and Vulnerable Plaque
Current Pharmaceutical Design Stem Cell Therapy in Heart Diseases: A Review of Selected New Perspectives,Practical Considerations and Clinical Applications
Current Cardiology Reviews A Practical Guide for the Treatment of Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF)
Current Cardiology Reviews Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Current Drug Targets Targeting Chromatin Remodeling to Prevent Cardiovascular Disease in Diabetes
Current Pharmaceutical Biotechnology Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design Cardiac Workup of Ischemic Stroke
Current Cardiology Reviews Cardiac Multidetector Computed Tomography: Basic Physics of Image Acquisition and Clinical Applications
Current Cardiology Reviews Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews